NCT06085053View on ClinicalTrials.gov

A Clinical Trial of TQA3038 Injection in Healthy Adult Subjects

PHASE1RecruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Chronic Hepatitis b
Interventions
DRUG

TQA3038 injection

TQA3038 is an injection.

DRUG

TQA3038 injection matching placebo

Placebo injection contains no active substance.

Trial Locations (1)

40030

RECRUITING

Tongji Hospital, Wuhan

Sponsors
All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY